EDMONTON, Alberta, July 6 /PRNewswire-FirstCall/ -- Medical Services International Inc. (OTC:MSITF) wishes to announce that it will begin shipping its VScan HIV test kits into several European countries who are now doing their own testing rather than wait for Medical Services to get CE approval. Preliminary testing by departments of health in several European countries has resulted in test data from the VScan HIV test kit that exceeded expectations. Consequently, rather than wait for the Company to obtain a CE mark for its HIV test kit, these countries have decided to complete the necessary testing for regulatory approval themselves through their departments of health. Upon successful completion of the testing of the VScan HIV test kits by the departments of health, Medical Services will receive clearance to begin selling its VScan HIV test kit in that country. It has become apparent that there is a significant demand for a reliable, accurate HIV rapid test kit that uses whole blood and does not require medical facilities. The fact that the VScan detects the IgM antigen within 2 to 11 days of infection when other kits do not, makes it the most sensitive and accurate test kit available. Market studies show that the demand for an HIV test kit like the VScan HIV test kit will be in excess of 2 to 3 million kits per year. About VScan The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada. Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/ . NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies. DATASOURCE: Medical Services International Inc. CONTACT: Robert Talbot of Medical Services International Inc., +1-780-430-6363 Web site: http://www.medicalservicesintl.com/ http://www.minerva-biotech.com/

Copyright